Compare Piramal Healthcare with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs TTK HEALTHCARE - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES TTK HEALTHCARE PIRAMAL ENTERPRISES/
TTK HEALTHCARE
 
P/E (TTM) x 13.5 16.9 79.9% View Chart
P/BV x 0.9 1.4 63.4% View Chart
Dividend Yield % 2.1 1.1 180.9%  

Financials

 PIRAMAL ENTERPRISES   TTK HEALTHCARE
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
TTK HEALTHCARE
Mar-19
PIRAMAL ENTERPRISES/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs3,3031,215 271.8%   
Low Rs1,797610 294.5%   
Sales per share (Unadj.) Rs716.5444.4 161.2%  
Earnings per share (Unadj.) Rs79.717.2 462.1%  
Cash flow per share (Unadj.) Rs107.927.6 390.5%  
Dividends per share (Unadj.) Rs28.005.00 560.0%  
Dividend yield (eoy) %1.10.5 200.4%  
Book value per share (Unadj.) Rs1,477.5177.9 830.4%  
Shares outstanding (eoy) m184.4514.13 1,305.4%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x3.62.1 173.3%   
Avg P/E ratio x32.052.9 60.5%  
P/CF ratio (eoy) x23.633.0 71.5%  
Price / Book Value ratio x1.75.1 33.6%  
Dividend payout %35.129.0 121.2%   
Avg Mkt Cap Rs m470,29212,894 3,647.3%   
No. of employees `0007.82.3 338.2%   
Total wages/salary Rs m22,5041,307 1,721.8%   
Avg. sales/employee Rs Th16,899.42,715.7 622.3%   
Avg. wages/employee Rs Th2,877.7565.3 509.0%   
Avg. net profit/employee Rs Th1,879.9105.4 1,783.5%   
INCOME DATA
Net Sales Rs m132,1536,279 2,104.8%  
Other income Rs m3,12878 4,036.1%   
Total revenues Rs m135,2816,356 2,128.3%   
Gross profit Rs m66,290496 13,375.6%  
Depreciation Rs m5,202147 3,545.7%   
Interest Rs m44,09734 130,465.7%   
Profit before tax Rs m20,119393 5,124.5%   
Minority Interest Rs m3,1940-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,611149 5,783.3%   
Profit after tax Rs m14,701244 6,032.5%  
Gross profit margin %50.27.9 635.5%  
Effective tax rate %42.837.9 112.9%   
Net profit margin %11.13.9 286.6%  
BALANCE SHEET DATA
Current assets Rs m122,7422,717 4,517.2%   
Current liabilities Rs m310,8101,571 19,786.7%   
Net working cap to sales %-142.318.3 -779.4%  
Current ratio x0.41.7 22.8%  
Inventory Days Days2332 71.7%  
Debtors Days Days3947 83.3%  
Net fixed assets Rs m116,904991 11,796.6%   
Share capital Rs m369141 261.1%   
"Free" reserves Rs m272,1612,373 11,469.1%   
Net worth Rs m272,5302,514 10,839.2%   
Long term debt Rs m270,1963 7,946,947.1%   
Total assets Rs m856,2614,158 20,592.6%  
Interest coverage x1.512.6 11.5%   
Debt to equity ratio x1.00 73,316.7%  
Sales to assets ratio x0.21.5 10.2%   
Return on assets %6.96.7 102.9%  
Return on equity %5.49.7 55.7%  
Return on capital %12.416.9 73.3%  
Exports to sales %03.6 0.0%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m15,200225 6,749.7%   
Fx outflow Rs m4,88971 6,875.0%   
Net fx Rs m10,312154 6,691.9%   
CASH FLOW
From Operations Rs m-115,975173 -66,998.6%  
From Investments Rs m-8,26597 -8,564.9%  
From Financial Activity Rs m107,525-307 -34,990.2%  
Net Cashflow Rs m-16,650-38 44,165.0%  

Share Holding

Indian Promoters % 52.9 65.4 80.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 3.7 108.1%  
FIIs % 26.6 5.2 511.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 25.8 64.0%  
Shareholders   93,274 12,723 733.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   STERLING BIOTECH  NOVARTIS  ALEMBIC PHARMA  ORCHID PHARMA LTD  SANOFI INDIA  

Compare PIRAMAL ENTERPRISES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

What Should You Do in Today's Volatile Markets?(Podcast)

The week gone by was pretty volatile for Dalal street and the global environment is as unpredictable as it can get.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

Small Cap Stocks Could Triple in Less than 2 Years... Here's Why(Profit Hunter)

Sep 30, 2019

Historical data backs up my conviction.

What if Indiabulls Housing Finance and Yes Bank Do Not Rebound?(Profit Hunter)

Oct 1, 2019

How long should you wait for fallen blue chips like Yes Bank and Indiabulls Housing Finance to rebound?

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Interest Rates Are Low. Buy Solid Dividend Stocks Instead(The 5 Minute Wrapup)

Sep 30, 2019

Select dividend stocks can be very rewarding.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Oct 11, 2019 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES - WYETH LTD COMPARISON

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS